Australia's largest stock trading and investment forum Australia's #1 stock forum

NEU

Click for more information

1.33%

$20.73 neuren pharmaceuticals limited

Neuren Media and Analyst Coverage, page-9

First 9 Last

Share
Profile

Follow
Potstock88

425 Posts.

146

13/12/21

16:42

Post #: 58261771
Share

Originally posted by hottod: ↑

I think that MST Access is more likely to be right on this, as it was engaged by Neuren. MST states that the ACAD agreement includes “payments over CY22/23 on FDA approval and market entry”.

Also, in the results conference last week, Jon Pilcher talked about expected payments based on the assumption that the FDA approves trofinetide and that the product is launched.

It’s possible that NDA filing will trigger a payment, but it looks likely that the first payment will be due on FDA approval which, if all goes well, could be next November or December.

Expand

Hi hottod. I refer you to the webcast where JP is speaking. He makes it quite clear that the first milestone payment will be in early 2022.

NEU Price at posting: $4.01 Sentiment: Buy Disclosure: Held
10 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 972 more messages in this thread...

First 9 Last

Add NEU (ASX) to my watchlist

(20min delay)
Last $20.73		Change -0.280(1.33%)		Mkt cap ! $2.647B

Open	High	Low	Value	Volume
$20.87	$21.19	$20.70	$6.213M	297.7K

Buyers (Bids)

No.	Vol.	Price($)
4	5414	$20.72

Sellers (Offers)

Price($)	Vol.	No.
$20.79	335	1

View Market Depth

No.	Vol.	Price($)
2	1072	20.720
1	1089	20.670
3	3987	20.660
1	50	20.650
2	2292	20.630

Price($)	Vol.	No.
20.850	1080	2
20.860	1089	1
20.890	1089	2
20.930	1089	1
20.960	1089	1

Last trade - 16.10pm 21/05/2024 (20 minute delay)


Last $20.73			Change -0.280 ( 1.22 %)
Open	High		Low	Volume
$20.99	$21.19		$20.69	94423
Last updated 15.59pm 21/05/2024 ?

NEU (ASX) Chart

SPONSORED BY